Maxidex

Dexamethasone, the active ingredient in Maxidex, is a corticosteroid presented as an ophthalmic suspension for ocular use. It reduces ocular inflammation and pain in conditions such as postoperative inflammation, anterior uveitis, and allergic conjunctivitis, providing targeted anti‑inflammatory action within the eye.

GNH USA supplies Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maxidex (dexamethasone) is used to manage inflammatory eye conditions by suppressing ocular immune responses. - Post‑operative ocular inflammation: reduces swelling, pain and redness after eye surgery. - Anterior uveitis: controls intra‑ocular inflammation and prevents tissue damage. - Allergic conjunctivitis: alleviates itching, redness and swelling caused by allergic reactions.

Ocular administration of dexamethasone may be associated with a range of local and systemic adverse reactions.

Common Side Effects: - Increased intra‑ocular pressure: mild rise detectable during treatment. - Blurred vision: temporary visual disturbance. - Eye irritation or burning: mild discomfort on instillation. - Conjunctival hyperemia: redness of the eye.

Serious or Rare Side Effects: - Secondary ocular infection: bacterial or fungal infection due to immunosuppression. - Steroid‑induced glaucoma: progressive optic nerve damage from sustained pressure elevation. - Posterior subcapsular cataract: lens opacity developing with prolonged use.

When prescribing Maxidex, clinicians should consider several precautionary measures to minimize risks. - Monitor intra‑ocular pressure: check pressure regularly during therapy. - Avoid in viral ocular infections: may exacerbate herpes simplex or zoster keratitis. - Use the lowest effective dose: limit duration to reduce cataract risk. - Caution in diabetic patients: steroids can raise blood glucose levels. - Store at room temperature: keep in the original container, protect from moisture and light.

Dexamethasone eye drops can interact with other medications, affecting efficacy or safety.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase systemic steroid exposure and side‑effects. - Antiviral eye medications (e.g., ganciclovir): may reduce antiviral effectiveness in viral keratitis.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase ocular steroid levels. - Non‑steroidal anti‑inflammatory eye drops: additive risk of delayed wound healing. - Anticholinergic agents: may exacerbate intra‑ocular pressure elevation.